Physician profile
Samuel Yost
NPI 1114978079
$3,677.82
in general payments reported to CMS, 2019-2025
15 companies · $804 in 2025
The $804 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $22.33 · 2022: $213 · 2023: $2,120 · 2024: $518 · 2025: $804.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,436 · Food and Beverage: $1,424 · Long Term Medical Supply Or Device Loan: $581.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,436.40 |
| Food and Beverage | $1,424.47 |
| Long Term Medical Supply Or Device Loan | $581.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,246.98 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Strattice Reconstructive Tissue Matrix Bps, Alloderm |
| Integra Lifesciences Corporation | $673.38 | 2022-2025 | Cytal, Integra, Integra Dermal Regeneration Template |
| Smith+Nephew, INC. | $229.41 | 2022-2024 | Collagenase Santyl, Renasys Touch, Renasys Go V2 Home |
| Becton, Dickinson and Company | $157.32 | 2023-2024 | Phasix Mesh |
| Advanced Oxygen Therapy INC. | $105.92 | 2022-2023 | Topical Oxygen Chamber For Extremities |
| Allergan, INC. | $46.36 | 2020-2022 | |
| Aroa Biosurgery Incorporated | $38.99 | 2024 | |
| Molnlycke Health Care US, LLC | $36.40 | 2025 | Mepitel One, Mepilex, Mextra Superabsorbant |
| Solventum Corporation | $34.30 | 2024 | Activ.A.C. |
| Kci USA, INC. | $22.27 | 2023 | Promogran Prisma, Prevena, V.A.C. Dermatac |
| Tela Bio, INC. | $20.72 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Bioventus LLC | $18.52 | 2022 | |
| Axogen | $17.51 | 2024 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Protector |
| Convatec INC. | $17.24 | 2025 | |
| Kerecis Limited | $12.50 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Yost listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.